Advanced search
1 file | 629.52 KB

Immunological diversity in phenotypes of chronic lung allograft dysfunction : a comprehensive immunohistochemical analysis

(2017) TRANSPLANT INTERNATIONAL. 30(2). p.134-143
Author
Organization
Abstract
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune response directed against the allograft. In lung transplantation, chronic rejection is nowadays clinically defined as a cause of chronic lung allograft dysfunction (CLAD), consisting of different clinical phenotypes including restrictive allograft syndrome (RAS) and bronchiolitis obliterans syndrome (BOS). However, the differential role of humoral and cellular immunity is not investigated up to now. Explant lungs of patients with end-stage BOS (n = 19) and RAS (n = 18) were assessed for the presence of lymphoid (B and T cells) and myeloid cells (dendritic cells, eosinophils, mast cells, neutrophils, and macrophages) and compared to nontransplant control lung biopsies (n = 21). All myeloid cells, with exception of dendritic cells, were increased in RAS versus control (neutrophils, eosinophils, and mast cells: all P < 0.05, macrophages: P < 0.001). Regarding lymphoid cells, B cells and cytotoxic T cells were increased remarkably in RAS versus control (P < 0.001) and in BOS versus control (P < 0.01). Interestingly, lymphoid follicles were restricted to RAS (P < 0.001 versus control and P < 0.05 versus BOS). Our data suggest an immunological diversity between BOS and RAS, with a more pronounced involvement of the B-cell response in RAS characterized by a structural organization of lymphoid follicles. This may impact future therapeutic approaches.
Keywords
antibody-mediated rejection, broncho-alveolar lavage fluid, chronic lung allograft dysfunction, immunohistochemistry, BRONCHIOLITIS OBLITERANS SYNDROME, ANTIBODY-MEDIATED REJECTION, IDIOPATHIC PULMONARY-FIBROSIS, TRANSPLANTATION, MECHANISMS, IMMUNITY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 629.52 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vandermeulen, Elly, Elise Lammertyn, Stijn E Verleden, David Ruttens, Hannelore Bellon, Mario Ricciardi, Jana Somers, et al. 2017. “Immunological Diversity in Phenotypes of Chronic Lung Allograft Dysfunction : a Comprehensive Immunohistochemical Analysis.” Transplant International 30 (2): 134–143.
APA
Vandermeulen, E., Lammertyn, E., Verleden, S. E., Ruttens, D., Bellon, H., Ricciardi, M., Somers, J., et al. (2017). Immunological diversity in phenotypes of chronic lung allograft dysfunction : a comprehensive immunohistochemical analysis. TRANSPLANT INTERNATIONAL, 30(2), 134–143.
Vancouver
1.
Vandermeulen E, Lammertyn E, Verleden SE, Ruttens D, Bellon H, Ricciardi M, et al. Immunological diversity in phenotypes of chronic lung allograft dysfunction : a comprehensive immunohistochemical analysis. TRANSPLANT INTERNATIONAL. 2017;30(2):134–43.
MLA
Vandermeulen, Elly et al. “Immunological Diversity in Phenotypes of Chronic Lung Allograft Dysfunction : a Comprehensive Immunohistochemical Analysis.” TRANSPLANT INTERNATIONAL 30.2 (2017): 134–143. Print.
@article{8500536,
  abstract     = {Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune response directed against the allograft. In lung transplantation, chronic rejection is nowadays clinically defined as a cause of chronic lung allograft dysfunction (CLAD), consisting of different clinical phenotypes including restrictive allograft syndrome (RAS) and bronchiolitis obliterans syndrome (BOS). However, the differential role of humoral and cellular immunity is not investigated up to now. Explant lungs of patients with end-stage BOS (n = 19) and RAS (n = 18) were assessed for the presence of lymphoid (B and T cells) and myeloid cells (dendritic cells, eosinophils, mast cells, neutrophils, and macrophages) and compared to nontransplant control lung biopsies (n = 21). All myeloid cells, with exception of dendritic cells, were increased in RAS versus control (neutrophils, eosinophils, and mast cells: all P < 0.05, macrophages: P < 0.001). Regarding lymphoid cells, B cells and cytotoxic T cells were increased remarkably in RAS versus control (P < 0.001) and in BOS versus control (P < 0.01). Interestingly, lymphoid follicles were restricted to RAS (P < 0.001 versus control and P < 0.05 versus BOS). Our data suggest an immunological diversity between BOS and RAS, with a more pronounced involvement of the B-cell response in RAS characterized by a structural organization of lymphoid follicles. This may impact future therapeutic approaches.},
  author       = {Vandermeulen, Elly and Lammertyn, Elise and Verleden, Stijn E and Ruttens, David and Bellon, Hannelore and Ricciardi, Mario and Somers, Jana and Bracke, Ken and Van Den Eynde, Kathleen and Tousseyn, Thomas and Brusselle, Guy and Verbeken, Erik K and Verschakelen, Johny and Emonds, Marie-Paule and Van Raemdonck, Dirk E and Verleden, Geert M and Vos, Robin and Vanaudenaerde, Bart M},
  issn         = {0934-0874},
  journal      = {TRANSPLANT INTERNATIONAL},
  keywords     = {antibody-mediated rejection,broncho-alveolar lavage fluid,chronic lung allograft dysfunction,immunohistochemistry,BRONCHIOLITIS OBLITERANS SYNDROME,ANTIBODY-MEDIATED REJECTION,IDIOPATHIC PULMONARY-FIBROSIS,TRANSPLANTATION,MECHANISMS,IMMUNITY},
  language     = {eng},
  number       = {2},
  pages        = {134--143},
  title        = {Immunological diversity in phenotypes of chronic lung allograft dysfunction : a comprehensive immunohistochemical analysis},
  url          = {http://dx.doi.org/10.1111/tri.12882},
  volume       = {30},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: